23 Jul, 2026
According to Straits Research the global cbd skin care products market was valued at $2.26 billion in 2025 and is anticipated to grow from $3 billion in 2026 to $28.31 billion by 2034, registering a CAGR of 32.4% during the forecast period 2026–2034. The regulatory landscape for the utility of cannabidiol (CBD) in beauty products remains stringent. As inspections are set to increase, manufacturing sectors are laying emphasis on compliance.
The CBD skin care products market is driven by the increasing consumer preference for natural, plant-based, and wellness-focused personal care products. Growing awareness of the potential anti-inflammatory, antioxidant, and soothing properties of cannabidiol (CBD) has encouraged its incorporation into skincare products such as creams, serums, lotions, balms, and facial oils. Rising demand for clean-label beauty products and increasing consumer interest in holistic skincare solutions are further supporting market growth.
The market is also benefiting from continuous product innovation, expanding product portfolios, and the growing presence of premium beauty brands offering CBD-infused skincare solutions. The rapid expansion of e-commerce platforms and direct-to-consumer sales channels has improved product accessibility, while increasing investments in research and development are enabling manufacturers to introduce advanced formulations for various skin concerns.
However, the market continues to face challenges due to the stringent regulatory landscape governing the use of cannabidiol in cosmetic products. Manufacturers are placing greater emphasis on regulatory compliance, product quality, and ingredient transparency to meet evolving legal requirements and consumer expectations. Despite these challenges, ongoing innovation, increasing consumer acceptance, and expanding legalization of CBD products in several countries are expected to support the long-term growth of the CBD skin care products market.
Regulations Regarding the Use of CBD in Beauty Products
EU
The utilization of cannabidiol in the beauty care segment is harmonized within the European Cosmetic Regulation 1223/2009, under entry 306 Narcotics, Natural, and Synthetic. The regulation prohibits the use of cannabis extract in cosmetics as it is a banned substance in Schedule 1 of the single convention on Narcotics Drugs.
Australia
Australia strictly regulated the use of CBD in the personal care industry, limiting the sales of CBD skincare products in the country. Under the Australian Law, plant growers cannot harvest the hemp plant unless it is licensed by the Federal Office for Drug Control under stringent security conditions. Officials claimed that CBD skincare products prescribed by physicians do not achieve accurate results, which eventually led to their discontinuation.
sales@straitsresearch.com